• Understand the Impacts of the Proposed Marijuana Reclassification

    June 7, 2024

    On May 21, 2024, the Department of Justice (DOJ) proposed a rule which, if enacted, would “transfer marijuana from schedule I of the Controlled Substances Act (CSA) to schedule III of the CSA.”1 Before the rule can be enacted, a 60 day comment period is given to allow members of the public to voice their […]

  • The Federal Trade Commission and The Department of Labor Announce Final Rules that Impact Employers

    April 24, 2024

    Employers Hit With Double April Whammy! On a day that may be remembered as Armageddon Tuesday by Employers, the Federal Trade Commission (FTC) and The Department of Labor (DOL) both announced final rules on Tuesday, April 23, 2024, that will have major implications for virtually every employer. The Federal Trade Commission rule bans almost all […]

  • American Privacy Rights Act: Key Lawmakers Reach Compromise on Bipartisan, Bicameral Comprehensive Data Privacy Legislation

    April 15, 2024

    On April 7, 2024, nearly two years after Congress’s last attempt to pass a national data privacy law, Senator Maria Canwell, chair of the Senate Commerce Committee, and Rep. Cathy McMorris Rodgers, Chair of the House Energy and Commerce Committee, unveiled the American Privacy Rights Act of 2024 (the “Act”). With an increasing number of […]

  • Alabama Federal Court Finds Corporate Transparency Act Unconstitutional: Why Your Business Still Needs to Comply

    March 6, 2024

    What happened? On March 1, 2024, a federal district court in Alabama held the Corporate Transparency Act (“CTA”) – federal legislation that requires businesses to submit beneficial ownership information reports (a “BOI Report”) – to be unconstitutional. In this particular case, the National Small Business Association sought injunctive relief which would prevent the application of […]

  • Understanding the Legal Risk for Healthcare Providers Regarding Controlled Substances

    February 19, 2024

    Controlled substances are medications that are regulated by the federal government. They include opioids, benzodiazepines, and stimulants. Over the last 25 years, controlled substances have come under increasing regulatory scrutiny, in part because of the opioid epidemic, and in part because the medical and scientific community has learned more about the risks associated with prescribing […]

  • Rhoades McKee Obtains Complete Dismissal of LARA Administrative Complaint

    February 12, 2024

    The Michigan Department of Licensing and Regulatory Affairs (LARA) has considerable power to issue sanctions against healthcare providers under Michigan law. Once LARA files an administrative complaint against an individual healthcare provider, it is unusual for LARA to dismiss such a complaint without administering a sanction. Therefore, Rhoades McKee attorney, Douglas Vanden Berge, was pleased when […]

  • New Reporting Requirements for Businesses Under the Corporate Transparency Act

    October 19, 2023

    Beginning on January 1, 2024, your business may have new reporting requirements under the Corporate Transparency Act (the “CTA”). On September 29, 2022, the Financial Crimes Enforcement Network (“FinCEN”) issued a final rule implementing the CTA’s beneficial ownership reporting provisions. The final rule requires anyone who is considered a “beneficial owner” or “company applicant” of […]

  • Back to School Essentials – Estate Planning Documents for College Students

    August 18, 2023

    As many parents help their college students pack for a dorm room or apartment, they are focused on the obvious essentials like a mini fridge, laptop, bedding, and cleaning supplies. Have you ever stopped to consider that as your children turn 18 they become legal adults? Our laws afford 18-year-olds more freedom and responsibility while […]

  • COUNTING THE (HOLI)DAYS: Department of Labor Confirms FMLA Leave Calculation for Weeks that Include Holidays

    June 7, 2023

    The Department of Labor recently issued an opinion clarifying when a holiday counts against an employee’s leave under the Family Medical Leave Act (FMLA). Although the opinion isn’t ground-breaking (indeed it restates what the regulations say and how the Act has been enforced), it’s still a good reminder of how to properly calculate intermittent FMLA […]

  • National Labor Relations Board WADES INTO NON-COMPETE DEBATE

    June 1, 2023

    Financial Danger Ahead! Despite the fact that non-compete and non-solicitation agreements are specifically allowed by statute in the vast majority of the States, the National Labor Relations Board (“NLRB”) is poised to challenge the legality of many such agreements as a violation of employee rights under the National Labor Relations Act (the “Act”). In an […]

Stay Informed

Join our mailing list today